Abbott today announced the U.S. Food and Drug Administration (FDA) has approved the company's CardioMEMS™ HERO device – a next-generation pulmonary artery (PA) pressure reader – to support the care of people living with heart failure. The reader contains new design features to help empower heart failure patients and their clinicians with the daily insights they need to detect and combat heart failure progression. Abbott will soon begin commercial release of the CardioMEMS HERO reader in the United States.

• No comments yet. Be the first to comment!